Synthesis, cytotoxicity and topoisomerase II inhibitory activity of lomefloxacin derivatives

Bioorganic & Medicinal Chemistry Letters
2013.0

Abstract

A novel series of amide derivatives of lomefloxacin were synthesized and evaluated for their topoisomerase I and II inhibitory activity as well as cytotoxicity against a panel of five human cancer cell lines. Of the compounds prepared compounds 9d and 9g exhibited strong inhibition against topoisomerase II at 100μM. In addition, docking studies were performed to predict the inhibition mode.

Knowledge Graph

Similar Paper

Synthesis, cytotoxicity and topoisomerase II inhibitory activity of lomefloxacin derivatives
Bioorganic & Medicinal Chemistry Letters 2013.0
2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure–activity relationship, and docking study
Bioorganic & Medicinal Chemistry Letters 2010.0
Synthesis and antitumor activity of novel benzimidazole-5-carboxylic acid derivatives and their transition metal complexes as topoisomerease II inhibitors
European Journal of Medicinal Chemistry 2010.0
Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors
European Journal of Medicinal Chemistry 2015.0
Synthesis of rotenoid derivatives with cytotoxic and topoisomerase II inhibitory activities
Bioorganic & Medicinal Chemistry Letters 2011.0
Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship
Bioorganic & Medicinal Chemistry 2010.0
Synthesis and biological evaluation of N -(carbobenzyloxy)- l -phenylalanine and N -(carbobenzyloxy)- l -aspartic acid- β -benzyl ester derivatives as potent topoisomerase IIα inhibitors
Bioorganic & Medicinal Chemistry 2017.0
Synthesis, cytotoxicity, and DNA topoisomerase II inhibitory activity of benzofuroquinolinediones
Bioorganic & Medicinal Chemistry 2007.0
Topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship study of dihydroxylated 2,6-diphenyl-4-aryl pyridines
Bioorganic & Medicinal Chemistry 2015.0
4-(1,2-diarylbut-1-en-1-yl)isobutyranilide derivatives as inhibitors of topoisomerase II
European Journal of Medicinal Chemistry 2016.0